Adult subjects with de novo or treatment-emergent neuroendocrine prostate cancer research hub

A Phase 1b Study of AMG 757 in Subjects with Neuroendocrine Prostate Cancer

This study is looking into a new medicine called AMG 757 for men who have a specific type of prostate cancer called neuroendocrine prostate cancer. It's an early-stage study to check the safety and how the new medicine works in the body.